 1.  Short title This Act may be cited as the  Lowest Price for Patients Act .
 2.  Requirement for pharmacies to disclose any differential between the cost of a prescription drug based on whether certain individuals use prescription drug coverage to acquire such drug  (a)  Enrollees of prescription drug coverage under a group health plan or a health insurance issuer offering group or individual health insurance coverage Section 2729(a) of the Public Health Service Act ( 42 U.S.C. 300gg–29(a) ) is amended— (1)  in paragraph (1)—  (A) by striking  not restrict, directly or indirectly,  and inserting  provide that ; and (B) by striking  from informing (or penalize such pharmacy for informing)  and inserting  inform ; and (2)  in paragraph (2)—  (A) by striking  ensure  and inserting  provide ; (B) by striking  does not, with respect to such plan or coverage, restrict, directly or indirectly,  and inserting  requires under such contract that ; and (C) by striking  from informing (or penalize such pharmacy for informing)  and inserting  inform . (b)  Enrollees of prescription drug coverage under a prescription drug plan or MA–PD plan Section 1860D–4 of the Social Security Act ( 42 U.S.C. 1395w–104 ) is amended— (1)  by redesignating the subsection (m) as inserted by section 6063(c) of the SUPPORT for Patients and Communities Act as subsection (n); and  (2)  by adding at the end the following new subsection:  (o)  Pharmacy disclosure of the price of a drug for an enrollee using and not using prescription drug coverage  For plan year 2022 and each subsequent plan year, a PDP sponsor and a Medicare Advantage organization offering a prescription drug plan or MA–PD plan under a contract with an entity that provides pharmacy benefits management services on behalf of such MA–PD plan shall provide that each pharmacy that dispenses a coverage part D drug shall inform an enrollee of any differential between—  (1)  the price of the drug for an individual that is an enrollee under such prescription drug plan or MA–PD plan (as the case may be) using such plan; and  (2)  the price of the drug for such individual described in paragraph (1) without using such plan.  . 
